GlaxoSmithkline Consumer Healthcare has informed that the Board of Directors of the Company at its meeting held on August 06, 2014, inter alia, on recommendation of the Nomination & Remuneration Committee, appointed Sangeeta Talwar, as an Independent Director of the Company, in the casual vacancy created by the resignation of Ireena Vlttal.
The above information is a part of company’s filings submitted to BSE